Ann: Response to ASX Price Query, page-66

We've had an approach to market process where a range of other joint ventures and consortiums, a combination of scientific and manufacturing bodies have come to us with their proposals as to how they might establish that capacity. That is very much a capacity about Australia's future medical needs. I mean, we will have all of the vaccinations we need to reach our markers and go forward without domestic manufacturing capabilities. And realistically, no country in the world has been able to establish outside of Pfizer and Moderna domestic manufacturing capabilities for this …